We were honoured to attend the Break Through Cancer Summit in Baltimore, a gathering that brought together leaders from across the childhood cancer community to focus on one shared goal: accelerating progress for children who urgently need better options.

Throughout the Summit, we witnessed something powerful taking shape. The $15M Defying Osteosarcoma TeamLab a first of its kind initiative stands as a real example of what can happen when researchers, clinicians, and foundations choose to work differently. We have committed $500k to this project. It is a model of true radical collaboration: breaking down silos, sharing data openly, and aligning expertise across major institutions to drive discoveries faster and with greater impact.

We were deeply inspired by the scientists leading this effort, including Alejandro Sweet Cordero (UCSF), Katherine Janeway (Dana Farber UCSF), Jonathan Gill (MD Anderson), Cheryl London (Tufts University), Melanie Rouleau (Dr Sorensens Team), and Mina Pichavant (Stanford). Their commitment to advancing osteosarcoma research, and their willingness to work together across disciplines and institutions, reflects the urgency felt by every family affected by this disease.

It was also a privilege to stand alongside Break Through Cancers extraordinary team and so many committed partners, the Osteosarcoma Institute, Battle Osteosarcoma, the Terry Fox Foundation and others who are helping to drive this movement forward. Each organisation brings its own strengths, and together they form a community determined to push the field beyond what has been possible before.

The atmosphere at the Summit was one of momentum and purpose. Real change is happening. The Defying Osteosarcoma TeamLab is not just a project; it marks a shift in how research can and should be done for children facing rare and aggressive cancers.

We are proud to be part of this moment and even prouder to support the work that will shape the breakthroughs of tomorrow.